Litcius/Paper detail

Nickel atom-clusters nanozyme for boosting ferroptosis tumor therapy

Hongji Liu, Biao Yu, Can Zhou, Zhiming Deng, Hui Wang, Xin Zhang, Kai Wang

2024Materials Today Bio11 citationsDOIOpen Access PDF

Abstract

The translation of Fe-based agents for ferroptosis tumor therapy is restricted by the unstable iron valence state, the harsh catalytic environment, and the complex tumor self-protection mechanism. Herein, we developed a stable nickel-based single-atom-metal-clusters (NSAMCs) biocatalyst for efficient tumor ferroptosis therapy. NSAMCs with a nanowire-like nanostructure and hydrophilic functional groups exhibit good water-solubility, colloidal stability, negligible systemic toxicity, and target specificity. In particular, NSAMCs possess excellent peroxidase-like and glutathione oxidase-like activities through the synergistic influence between metal clusters and single atoms. The dual-enzymatic performance enables NSAMCs to synergistically promote efficient ferroptosis of cancer cells through lipid peroxidization aggregation and glutathione peroxidase 4 inactivation. Importantly, NSAMCs highlight the boost of ferroptosis tumor therapy via the synergistic effect between single-atoms and metal clusters, providing a practical and feasible paradigm for further improving the efficiency of ferroptosis tumor treatment.

Topics & Concepts

NickelBoosting (machine learning)Atom (system on chip)Materials scienceCancer researchMedicineComputer scienceMetallurgyArtificial intelligenceEmbedded systemAdvanced Nanomaterials in CatalysisNanocluster Synthesis and ApplicationsNanoplatforms for cancer theranostics
Nickel atom-clusters nanozyme for boosting ferroptosis tumor therapy | Litcius